Palouse Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-400
| Closed | -$21.7K | – | 122 |
|
|
2024
Q1 | $21.7K | Buy |
+400
| New | +$21.7K | 0.01% | 125 |
|
|
2022
Q1 | – | Sell |
-90,553
| Closed | -$5.65M | – | 102 |
|
|
2021
Q4 | $5.65M | Sell |
90,553
-5,432
| -6% | -$339K | 2.41% | 10 |
|
|
2021
Q3 | $5.68M | Sell |
95,985
-2,432
| -2% | -$144K | 2.52% | 13 |
|
|
2021
Q2 | $6.58M | Sell |
98,417
-399
| -0.4% | -$26.7K | 2.87% | 4 |
|
|
2021
Q1 | $6.24M | Buy |
98,816
+33,847
| +52% | +$2.14M | 2.75% | 5 |
|
|
2020
Q4 | $4.03M | Sell |
64,969
-7,109
| -10% | -$441K | 2.13% | 14 |
|
|
2020
Q3 | $4.35M | Sell |
72,078
-15,531
| -18% | -$936K | 2.43% | 13 |
|
|
2020
Q2 | $5.15M | Sell |
87,609
-3,262
| -4% | -$192K | 2.72% | 7 |
|
|
2020
Q1 | $5.07M | Sell |
90,871
-3,708
| -4% | -$207K | 2.99% | 6 |
|
|
2019
Q4 | $6.07M | Sell |
94,579
-5,984
| -6% | -$384K | 2.3% | 14 |
|
|
2019
Q3 | $5.1M | Buy |
+100,563
| New | +$5.1M | 1.89% | 23 |
|